1. Targeting the DNA Damage Response Machinery for Lung Cancer Treatment
   Katharigatta N. Venugopala, 2022, Pharmaceuticals CrossRef
2. Clinical implications of aberrant PD-1 expression for acute leukemia prognosis
   Yanjie Ruan et al, 2023, European Journal of Medical Research CrossRef
3. The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy
   Lu Wen et al, 2021, Frontiers in Oncology CrossRef
4. Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines
   Marika Saar et al, 2023, Pharmaceutics CrossRef
5. Prediction of programmed death-1 expression status in non–small cell lung cancer based on intratumoural and peritumoral computed tomography (CT) radiomics nomogram
   Q. Tian et al, 2024, Clinical Radiology CrossRef
6. Lung Cancer in Estonia
   Tanel Laisaar et al, 2024, Journal of Thoracic Oncology CrossRef